Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice

European Journal of Neuroscience

Volumn 12, Issue 11, 2000, Pages 4038-4046

  Martin, Miquel ^a   Ledent, Catherine ^b   Parmentier, Marc ^b   Maldonado, Rafael ^a   Valverde, Olga ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Behavioural sensitization; CB1 cannabinoid receptors cocaine; Conditioning place preference; Knockout mice; Morphine

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR; COCAINE; MORPHINE;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVERSIVE BEHAVIOR; CONDITIONING; CONTROLLED STUDY; GENOTYPE; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOTIVATION; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; REWARD; SENSITIZATION;

EID: 0033777338     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2000.00287.x     Document Type: Article

References (40)

1. Cannabinoid receptor-regulated cyclic AMP accumulation in the rat striatum
2. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1
3. Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain
4. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
5. Pharmacology of some marijuana constituents and two heterocyclic analogues
6. Drug-induced reinstatement of heroin and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization
7. Neurobiology of opiate abuse
8. Gene-targeting studies of mammalian behavior: Is it the mutation or the background genotype?
9. Chronic (-)-Δ9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats
10. Interaction of Δ9-tetrahydrocannabinol and D-anphetamine
11. Morphine-dependent rats: Blockade of precipitated abstinence by tetrahydrocannabinol
12. Cannabinoid inhibition of adenylyl cyclase. Pharmacology of the response in neuroblastoma cell membranes
13. Neural mechanisms of drug reinforcement
14. Drug abuse: Hedonic homeostatic dysregulation
15. Neuroscience of addiction
16. Unresponsiveness to cannabinoid and reduced addictive effects of opiates in CB-1 receptor knockout mice
17. Conditioned place preference induced by Δ9-tetrahydrocannabinol comparison with cocaine, morphine and food reward
18. Spinal and supraspinal components of cannabinoid-induced antinociception
19. Distribution of the neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
20. Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308
21. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors
22. Pharmacological and biochemical interactions between opioids and cannabinoids
23. Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB1 receptor knockout mice
24. Comparative effects of tetrahydrocannabinol on psychostimulant-induced behaviours
25. CB-1 cannabinoid receptor antagonist-inducad opiate withdrawal in morphine-dependent rats
26. Molecular mechanisms of drug addiction
27. Interactions of Δ9-tetrahydrocannabinol with D-amphetamine, cocaine and nicotine in rats
28. Potentiation of Δ9-tetrahydrocannabinol-induced analgesia by morphine in mice: Involvement of μ- and k-opioid receptors
29. Activation of corticotropin-releasing factor in the limbic system during cannabinoids withdrawal
30. The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake
31. Sensitization to the conditioned rewarding effects of cocaine: Pharmacological and temporal characteristics
32. Sensitization to the conditioned rewarding effects of morphine: Pharmacology and temporal characteristics
33. Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal
34. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal
35. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mul opioid receptor mechanism
36. A behavioural model to reveal place preference to Δ9-tetrahydrocannabinol in mice
37. Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal
38. Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors
39. A single exposure to amphetamine is sufficient to induce long-term behavioural, neuroendocrine and neurochemical sensitization in rats
40. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1receptor knockout mice